reviewJournal of Nanomedicine & NanotechnologyJan 1, 2013HYBRID OA

Paclitaxel Nano-Delivery Systems: A Comprehensive Review

University of North Carolina at Chapel Hill

PubMed
Indexed incrossrefpubmed

Abstract

Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low water solubility, paclitaxel is formulated in a mixture of Cremophor EL and dehydrated ethanol (50:50, v/v) a combination known as Taxol. However, Taxol has some severe side effects related to Cremophor EL and ethanol. Therefore, there is an urgent need for the development of alternative Taxol formulations. The encapsulation of paclitaxel in biodegradable and non-toxic nano-delivery systems can protect the drug from degradation during circulation and in-turn protect the body from toxic side effects of the drug thereby lowering…

Citation impact

550
total citations
FWCI
13.93
Percentile
100%
References
208
Citations per year

Authors

1

Topics & keywords

Keywords
  • Paclitaxel
  • Drug delivery
  • Drug
  • Pharmacology
  • Targeted drug delivery
  • Nanocarriers
  • Drug carrier
  • Chemistry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding